semaglutide 0 25 mg Wegovy 0.25Mg Pen 4 Doses high blood pressure Semalix 0.25 mg/0.5 mg Pre-filled
Description
In late 2022, the FDA also approved semaglutide for the treatment of obesity in pediatric patients aged 12 and older [4]

Weighing in on the evidence

Diabetes and cardiovascular disease: an update

doi: 10.3945/ajcn.111.024927 [DOI] [PMC free article] [PubMed] [Google Scholar] 13.Kuna ST Reboussin DM Borradaile KE, et al
